Literature DB >> 7522922

Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons.

E J Van Bockstaele1, D M Cestari, V M Pickel.   

Abstract

Microinfusion of serotonin (5-hydroxytryptamine; 5-HT) into the ventral tegmental area enhances the release of dopamine in the nucleus accumbens, a major target of midbrain dopamine neurons. We examined the synaptic basis for 5-HT modulation of neurons in the ventral tegmental area which either (i) project to the nucleus accumbens or (ii) contain the catecholamine synthesizing enzyme tyrosine hydroxylase, a marker of dopamine neurons in this brain region. In the first study, immunoperoxidase labeling of 5-HT in the ventral tegmental area was combined with retrograde transport of gold particles following unilateral injections of the tracer into the nucleus accumbens of adult rats. The gold particles had been previously coupled to wheat germ agglutinin conjugated to inactive horseradish peroxidase. Gold particles were enlarged for visualization using a silver enhancement procedure. By brightfield microscopy, retrogradely labeled neurons contained black punctate granules within their perikarya and proximal processes. The labeled cells were scattered ipsilateral to the injection within the paranigral and parabrachial subdivisions of the ventral tegmental area. Both regions also contained 5-HT immunoreactive varicosities. By electron microscopy, irrespective of the ventral tegmental subdivision, 5-HT labeling was seen primarily in unmyelinated axons and axon terminals. The terminals contained small, clear and large dense core vesicles and ranged from 0.3 micron to 1.4 microns in cross-sectional diameter. 22% (n = 250) of the axon terminals containing 5-HT immunoreactivity formed synaptic contacts with neurons containing the retrograde label. Of these 5-HT terminals, 16% formed asymmetric type contacts and 6% formed symmetric junctions on the retrogradely labeled neurons. The remaining 5-HT terminals were either apposed to (but lacked recognized synapses on) perikarya and large dendrites containing the retrogradely transported protein-gold tracer or contacted unlabeled neurons. In the second set of experiments combining immunoperoxidase of 5-HT and immunogold silver for tyrosine hydroxylase, 32% (n = 250) of the 5-HT-labeled terminals formed synaptic junctions with perikarya or dendrites containing tyrosine hydroxylase immunoreactivity. Of these 5-HT terminals, 23% formed asymmetric type junctions. The remainder were either symmetric or lacked recognized membrane densities. The prominence of asymmetric junctions formed by 5-HT-labeled terminals on neurons projecting to the nucleus accumbens and those containing tyrosine hydroxylase in the ventral tegmental area suggests a cellular basis for serotonergic excitation of mesoaccumbens dopamine neurons. Additionally, the multiplicity of junctions formed by 5-HT terminals on targets with or without retrograde labeling or tyrosine hydroxylase immunoreactivity is consistent with known diverse physiological actions of 5-HT in the tegmental area.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522922     DOI: 10.1016/0006-8993(94)91330-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  30 in total

Review 1.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

2.  Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating.

Authors:  Kimberly A Brownley; Charlotte A Boettiger; Laura Young; William T Cefalu
Journal:  Med Hypotheses       Date:  2015-03-27       Impact factor: 1.538

Review 3.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

4.  Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.

Authors:  Paul J Fletcher; Fiona D Zeeb; Caleb J Browne; Guy A Higgins; Ashlie D Soko
Journal:  Psychopharmacology (Berl)       Date:  2017-01-18       Impact factor: 4.530

Review 5.  Synaptic and extrasynaptic secretion of serotonin.

Authors:  Francisco F De-Miguel; Citlali Trueta
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

6.  The stimulating effects of ethanol on ventral tegmental area dopamine neurons projecting to the ventral pallidum and medial prefrontal cortex in female Wistar rats: regional difference and involvement of serotonin-3 receptors.

Authors:  Zheng-Ming Ding; Scott M Oster; Sarah R Hall; Eric A Engleman; Sheketha R Hauser; William J McBride; Zachary A Rodd
Journal:  Psychopharmacology (Berl)       Date:  2011-02-23       Impact factor: 4.530

7.  Serotonin-3 receptors in the posterior ventral tegmental area regulate ethanol self-administration of alcohol-preferring (P) rats.

Authors:  Zachary A Rodd; Richard L Bell; Scott M Oster; Jamie E Toalston; Tylene J Pommer; William J McBride; James M Murphy
Journal:  Alcohol       Date:  2010-05       Impact factor: 2.405

8.  Lateral habenula projections to dopamine and GABA neurons in the rat ventral tegmental area.

Authors:  Natalia Omelchenko; Roland Bell; Susan R Sesack
Journal:  Eur J Neurosci       Date:  2009-09-29       Impact factor: 3.386

9.  Dose-response inhibitory effects of purified cathinone from khat (Catha edulis) on cortisol and prolactin release in vervet monkeys (Chlorocebus aethiops).

Authors:  Albert W Nyongesa; Jemimah A Oduma; Motohiro Nakajima; Hesbon O Odongo; Pius A Adoyo; Mustafa al'Absi
Journal:  Metab Brain Dis       Date:  2013-11-05       Impact factor: 3.584

10.  Novel research translates to clinical cases of schizophrenic and cocaine psychosis.

Authors:  João V Nunes; Patricia A Broderick
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.